Aigen Investment Management, LP Halozyme Therapeutics, Inc. Transaction History

Aigen Investment Management, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$33.68 - $41.95 $508,264 - $633,067	15,091 Added 168.77%	24,033 $977,000
Q4 2023 Feb 09, 2024	BUY	$33.32 - $42.1 $78,668 - $99,398	2,361 Added 35.88%	8,942 $330,000
Q3 2023 Nov 13, 2023	BUY	$36.46 - $44.03 $239,943 - $289,761	6,581 New	6,581 $251,000
Q2 2022 Aug 02, 2022	SELL	$37.35 - $48.3 $82,580 - $106,791	-2,211 Reduced 8.74%	23,084 $1.02 Million
Q1 2022 May 05, 2022	BUY	$31.97 - $41.06 $344,284 - $442,175	10,769 Added 74.14%	25,295 $1.01 Million
Q4 2021 Feb 11, 2022	BUY	$31.82 - $40.75 $86,009 - $110,147	2,703 Added 22.86%	14,526 $486,000
Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $454,830 - $548,823	11,823 New	11,823 $481,000
Q2 2021 Aug 10, 2021	SELL	$38.84 - $51.31 $799,832 - $1.06 Million	-20,593 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$39.51 - $51.45 $481,587 - $627,124	-12,189 Reduced 37.18%	20,593 $859,000
Q4 2020 Feb 12, 2021	SELL	$25.81 - $43.62 $441,273 - $745,771	-17,097 Reduced 34.28%	32,782 $1.4 Million
Q3 2020 Nov 06, 2020	BUY	$25.74 - $29.63 $1.07 Million - $1.24 Million	41,717 Added 511.11%	49,879 $1.31 Million
Q2 2020 Aug 10, 2020	BUY	$16.25 - $26.81 $84,581 - $139,546	5,205 Added 176.02%	8,162 $219,000
Q1 2020 May 08, 2020	SELL	$13.9 - $21.83 $522,292 - $820,262	-37,575 Reduced 92.7%	2,957 $53,000
Q4 2019 Feb 04, 2020	BUY	$14.93 - $19.53 $605,142 - $791,589	40,532 New	40,532 $719,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.